Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 June 2008

Ann Rheum Dis. Published Online First: 17 September 2007. doi:10.1136/ard.2007.077156
Copyright © 2007 BMJ Publishing Group Ltd & European League Against Rheumatism.

Extended Report

A randomised placebo-controlled interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus

Stephen A Wright 1*, Fiona M O'Prey 2, Michelle T McHenry 1, William J Leahey 2, Adrian B Devine 2, Emeir M Duffy 3, Dennis G Johnston 2, Michael B Finch 1, Aubrey L Bell 1 and Gary E McVeigh 2

1 Musgrave Park Hospital, United Kingdom
2 Queens University Belfast, United Kingdom
3 University of Ulster, United Kingdom

* To whom correspondence should be addressed. E-mail: drsawright{at}yahoo.co.uk.

Accepted 3 September 2007


Abstract

Objective: To determine the clinical effect of dietary supplementation with low dose omega-3-polyunsaturated fatty acids on disease activity and endothelial function in patients with systemic lupus erythematosus.

Methods: A 24 week randomised double-blind placebo-controlled parallel trial of the effect of 3g of omega-3-polyunsaturated fatty acids on 60 patients with SLE was performed. Serial measurements of disease activity using the revised Systemic Lupus Activity Measure (SLAM-R) and British Isles Lupus Assessment Group index of disease activity for SLE (BILAG), endothelial function using flow mediated dilation of the brachial artery (FMD), oxidative stress using platelet 8-isoprostanes and analysis of platelet membrane fatty acids were taken at baseline, 12 and 24 weeks.

Results: In the fish oil group there was a significant improvement at 24 weeks in SLAM-R (from 9.4±3.0 to 6.3±2.5, p<0.001); in BILAG (from 13.6±6.0 to 6.7±3.8, p<0.001); in FMD (from 3.0% (-0.5-8.2) to 8.9% (1.3-16.9), p<0.001) and in platelet 8-isoprostanes (from 177pg/mg protein (23 – 387) to 90 pg/mg protein (32 – 182), p = 0.007).

Conclusions: Low dose dietary supplementation with omega-3 fish oils in SLE not only has a therapeutic effect on disease activity but also improves endothelial function and reduces oxidative stress and may therefore confer cardiovascular benefits.

Keywords: endothelial function, fish oils, SLE


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Guillot, N., Caillet, E., Laville, M., Calzada, C., Lagarde, M., Vericel, E. (2009). Increasing intakes of the long-chain {omega}-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men. FASEB J. 23: 2909-2916 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs